A drug called leucovorin is being considered as a potential treatment for autism, with some outlets reporting it has been touted by the Trump administration. However, many scientists and medical professionals are skeptical about its effectiveness, and a pediatrics group has declined to recommend it. The FDA's involvement in the drug's potential use for autism treatment has also been reported, although the extent of its approval or recommendation is unclear.